The compound has become investigated in the patent literature for its anxiolytic properties and diminished sedative, hypnotic, and ataxic aspect-outcomes, but it does not appear to be accredited for clinical use. Łukasik-Głebocka et al Sadly, there are no common “therapeutic” concentrations of flubromazolam that may be correlated with clinical manifestations https://johnnywyyyw.illawiki.com/1541930/fascination_about_buy_flubromazolam